Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glycogenolysis stimulation in skeletal muscle is not a discrete molecular target or receptor, but rather a metabolic process governed by the enzyme glycogen phosphorylase (muscle isoform), which catalyzes the breakdown of glycogen to glucose-1-phosphate during muscle contraction or adrenergic stimulation. This process is essential for rapid ATP generation and is tightly regulated by allosteric and covalent modification mechanisms involving phosphorylase kinase, adenyl cyclase, cAMP, and catecholamines such as epinephrine and norepinephrine[3][4][2]. The activity of the muscle isoform of glycogen phosphorylase is critical for exercise performance and energy metabolism in skeletal muscle, and its disorder results in specific metabolic diseases.
Catalyzes phosphorolytic cleavage of glycogen to produce glucose-1-phosphate during muscle contraction and adrenergic stimulation[3][4]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycogen phosphorylase (muscle isoform) (none).